7 Reasons That Make Chemours (CC) A Solid Choice Right Now
Zacks Investment Research | Jul 14, 2017 08:57AM ET
The Chemours Company’s (NYSE:CC) stock looks promising at the moment. The company has seen its shares pop around 99% year to date. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s delve deeper into the factors that make this chemical company an attractive investment option.
What Working in Favor of Chemours? Solid Rank & VGM Score:
Upbeat Outlook: Chemours, in May, raised its outlook for full-year 2017 on the back of strong first-quarter results. The company now sees its adjusted EBITDA for 2017 to be in a band of $1.15 billion to $1.25 billion compared with its earlier view of over $1 billion.
Chemours also envisions strong performance for both Ti-Pure titanium dioxide and Opteon refrigerants. It is seeing healthy demand for these products and expects earnings in first-half and second-half 2017 to be more balanced than what it had witnessed last year. The company also noted that it is well placed for the balance of 2017 as it remains focused on strengthening its businesses and will benefit from favorable market conditions.
Estimates Northbound: Annual estimates for Chemours have moved north over the past three months, reflecting analysts’ confidence on the stock. Over this period, the Zacks Consensus Estimate for 2017 has increased by around 15.5% to $3.35 per share. The Zacks Consensus Estimate for 2018 has also moved up 13.3% over the same timeframe to $4.00.
Positive Earnings Surprise History: Chemours has an impressive earnings surprise history, outpacing the Zacks Consensus Estimate in three the trailing four quarters, delivering a positive average earnings surprise of 39.82%.
Solid Growth Prospects: The Zacks Consensus Estimate for earnings for 2017 for Chemours is currently pegged at $3.35, reflecting an expected year-over-year growth of a staggering 228.4%. Moreover, earnings are expected to register a 19.4% growth in 2018. The stock also has a long-term (3-5 years) expected expected earnings per share (EPS) growth rate of roughly 15.5%, higher than the industry average of 9.3%.
Get The News You Want
Superior Return on Equity (ROE): Chemours’ ROE of 125.7%, as compared with the industry average of 22.8%, manifests the company’s efficiency in utilizing shareholder’s funds.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.